Table 4.
p.16Arg/Arg | p.16Arg/Gly | p.16Gly/Gly | |
---|---|---|---|
Mothers | N = 18 | N = 19 | N = 8 |
Dose of ephedrine (mg) | 61 ± 26 | 72 ± 20 | 60 ± 29 |
MA ephedrine concentration (ng/ml) | 368.3 ± 186.4 | 449.2 ± 144.9 | 428.0 ± 243.2 |
UV ephedrine concentration (ng/ml) | 449.9 ± 250.9 | 488.2 ± 156.2 | 442.3 ± 122.2 |
UA/UV ratio | 0.83 ± 0.17 | 0.83 ± 0.12 | 0.77 ± 0.11 |
UV/MA ratio | 1.22 ± 0.27 | 1.09 ± 0.16 | 1.26 ± 0.24 |
Neonates | N = 10 | N = 28 | N = 7 |
UA ephedrine concentration (ng/ml) | 374.0 ± 204.4 | 402.8 ± 211.0 | 314.5 ± 101.0 |
UV ephedrine concentration (ng/ml) | 406.7 ± 191.2 | 481.3 ± 223.9 | 384.7 ± 163.6 |
UA/UV ratio | 0.90 ± 0.15 | 0.86 ± 0.20 | 0.83 ± 0.13 |
UV/MA ratio | 1.06 ± 0.21 | 1.19 ± 0.26 | 1.13 ± 0.14 |
N = 9 | N = 28 | N = 7 | |
UA pH | 7.30 ± 0.02§ | 7.18 ± 0.11 | 7.22 ± 0.07 |
UA lactate (mmol/L) | 3.66 ± 1.30§§ | 6.10 ± 3.04 | 4.60 ± 1.86 |
Values are mean ± standard deviation.
One-way ANOVA, post hoc test: Bonferroni, and paired t-test.
p.16Arg/Arg different from p.16Arg/Gly p < 0.001 (95% C.I of difference 0.07 ~ 0.16); p.16Arg/Arg different from p.16Arg/Gly and p.16Gly/Gly combined (7.19± 0.10; p < 0.001, 95% C.I of difference 0.07 ~ 0.14).
p.16Arg/Arg different from p.16Arg/Gly, p = 0.002 (95% C.I of difference −3.92 ~ −0.96); p.16Arg/Arg different from p.16Arg/Gly and p.16Gly/Gly combined (5.79 ± 2.88; p = 0.003, 95% C.I of difference −3.48 ~ −0.80)
UA = umbilical artery; MA = maternal artery; UV = umbilical vein.